Catalyst Pharmaceuticals, a US biopharma company, is licensed by SERB and previously settled litigation with Teva Pharmaceuticals.
2 reports, 2 independent
Updated Aug 27
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Catalyst Pharmaceuticals, a US biopharma company, is licensed by SERB and previously settled litigation with Teva Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Catalyst Pharmaceuticals
company in Coral Gables, United States
Nothing else this week.
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
Coverage
Newest first; wire copies grouped- GlobeNewswireUPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals As Part of the Settlement, Lupin Receives a License to Market Generic
- PR NewswireCatalyst Solutions Announces Successful Launch of P3 Implementation Across Four States GREENWOOD VILLAGE, Colo., Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successfu